小儿耳鼻咽喉科临床试验回顾:过去趋势与未来机会
该研究回顾分析2001至2017年美国ClinicalTrials.gov注册的小儿耳鼻咽喉科介入性临床试验,共纳入122项已关闭试验。结果显示25%针对鼻炎、25%针对急性中耳炎,药物研究占72%,65%的结果发表于同行评议期刊,73%由工业界资助。作者认为应扩大研究疾病谱、提高结果发表率和联邦资助。
要点
- 小儿耳鼻咽喉科试验中鼻炎和急性中耳炎各占25%,其他病种合计50%。
- 药物研究占72%,65%的结果发表于同行评议期刊,73%由工业界资助。
- 需提高结果发表率与联邦资助以平衡试验布局。
核心结论
- 小儿耳鼻咽喉科临床试验需覆盖更广的疾病与治疗谱系,并提高结果发表率和联邦资助以促进均衡发展。
研究设计与样本
- 回顾性分析2001至2017年美国ClinicalTrials.gov注册的小儿耳鼻咽喉科介入性临床试验,纳入至少一个试验组参与者小于18岁、已关闭且在美国进行的试验,共分析122项。
主要发现
- 122项试验中,25%研究鼻炎治疗,25%研究急性中耳炎,50%研究其他所有疾病。
- 药物研究占所有试验的72%。
- 65%的试验结果发表于同行评议期刊。
- 工业界资助占财政支持的73%。
关键数值与推荐
- 纳入标准:耳鼻咽喉科试验、至少一个试验组参与者小于18岁、介入性设计且已关闭、在美国进行。
临床怎么用
- 提示临床医生关注小儿耳鼻咽喉科试验集中于鼻炎和急性中耳炎、以药物研究为主且多由工业界资助的现状。
- 鼓励参与和推动覆盖更广疾病谱的临床试验,并关注结果发表。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Pediatric otolaryngologic conditions are highly prevalent in the United States. Although data gathered from clinical trials drive therapeutic strategies, the trends of research in pediatric otolaryngology remain unclear. The objective of this study was to characterize recent trials in pediatric otolaryngology to better understand current directions of study and to identify opportunities for future research. STUDY DESIGN: Retrospective analysis. METHODS: A retrospective analysis of United States pediatric clinical trials in otolaryngology between 2001 and 2017 was conducted on ClinicalTrials.gov. Criteria for inclusion included otolaryngologic trials with at least one trial arm of participants <18 years of age, interventional design that was closed, and conducted in the United States. We assessed the information available to us on ClinicalTrials.gov to identify recent trends in pediatric otolaryngology interventional research. We used PubMed to examine publication rates and National Institutes of Health RePORTER to characterize funding patterns for these trials. RESULTS: Of the 122 trials analyzed, 25% investigated treatments for rhinitis, 25% for acute otitis media, and 50% for all other conditions. Drug studies comprised 72% of all trials. Overall, 65% had their results published in a peer-reviewed journal. Industry funding accounted for 73% of financial support. CONCLUSIONS: Continued focus on the development of pediatric otolaryngologic clinical trials allows an opportunity to better represent the wide spectrum of disease and therapy in the specialty. Increasing the rates of results publication and federal funding may spearhead a more balanced landscape of clinical trials and further advance the care of children with otolaryngologic disease. LEVEL OF EVIDENCE: NA Laryngoscope, 130:2719-2724, 2020.
引用
- Shetty KR, Komshian SR, Devaiah A, et al. Review of Pediatric Otolaryngology Clinical Trials: Past Trends and Future Opportunities. Laryngoscope. 2020. PMID: 31994735. doi:10.1002/lary.28511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。